IL270355B1 - - Google Patents
Info
- Publication number
- IL270355B1 IL270355B1 IL27035519A IL27035519A IL270355B1 IL 270355 B1 IL270355 B1 IL 270355B1 IL 27035519 A IL27035519 A IL 27035519A IL 27035519 A IL27035519 A IL 27035519A IL 270355 B1 IL270355 B1 IL 270355B1
- Authority
- IL
- Israel
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0085—Brain, e.g. brain implants; Spinal cord
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Virology (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Psychology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Epoxy Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/IL2017/050535 WO2018211486A1 (en) | 2017-05-15 | 2017-05-15 | Treatment of multiple sclerosis with long acting glatiramer and adipose-derived stem cells |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| IL270355A IL270355A (cg-RX-API-DMAC7.html) | 2019-12-31 |
| IL270355B1 true IL270355B1 (cg-RX-API-DMAC7.html) | 2023-02-01 |
| IL270355B2 IL270355B2 (en) | 2023-06-01 |
Family
ID=64273438
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL270355A IL270355B2 (en) | 2017-05-15 | 2019-10-31 | Treatment of multiple sclerosis using long-acting glatiramer and stem cells derived from adipose tissue |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US11413311B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3624815A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7000458B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN110709091A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2017414803B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3062964C (cg-RX-API-DMAC7.html) |
| IL (1) | IL270355B2 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2018211486A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12097292B2 (en) | 2016-08-28 | 2024-09-24 | Mapi Pharma Ltd. | Process for preparing microparticles containing glatiramer acetate |
| DK3506921T3 (da) | 2016-08-31 | 2023-07-31 | Mapi Pharma Ltd | Depotsystemer, der omfatter glatirameracetat |
| US11167003B2 (en) * | 2017-03-26 | 2021-11-09 | Mapi Pharma Ltd. | Methods for suppressing or alleviating primary or secondary progressive multiple sclerosis (PPMS or SPMS) using sustained release glatiramer depot systems |
Family Cites Families (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL36670A (en) | 1971-04-21 | 1974-09-10 | Sela M | Therapeutic basic copolymers of amino acids |
| IL113812A (en) | 1994-05-24 | 2000-06-29 | Yeda Res & Dev | Copolymer-1 pharmaceutical compositions containing it and its use |
| US6214791B1 (en) | 1997-01-10 | 2001-04-10 | Yeda Research And Development Co. Ltd. | Treatment of multiple sclerosis through ingestion or inhalation of copolymer-1 |
| HK1054507B (zh) | 2000-01-20 | 2008-10-31 | 耶达研究及发展有限公司 | 共聚物1和相关肽和多肽及其处理过的t细胞在神经保护性治疗中的用途 |
| US8871241B2 (en) | 2002-05-07 | 2014-10-28 | Psivida Us, Inc. | Injectable sustained release delivery devices |
| PT1592384E (pt) | 2003-01-21 | 2013-01-28 | Yeda Res & Dev | Cop-1 para o tratamento de doenças inflamatórias do intestino |
| US7429378B2 (en) | 2003-05-13 | 2008-09-30 | Depuy Spine, Inc. | Transdiscal administration of high affinity anti-MMP inhibitors |
| EP1827108B1 (en) * | 2004-11-29 | 2015-04-08 | Yeda Research And Development Co., Ltd. | Induction of neurogenesis and stem cell therapy in combination with copolymer 1 |
| WO2006060779A2 (en) | 2004-12-03 | 2006-06-08 | Case Western Reserve University | Novel methods, compositions and devices for inducing neovascularization |
| US20070003528A1 (en) | 2005-06-29 | 2007-01-04 | Paul Consigny | Intracoronary device and method of use thereof |
| KR101378874B1 (ko) | 2005-10-13 | 2014-03-27 | 안트로제네시스 코포레이션 | 태반 줄기세포를 이용한 면역 조절 |
| EP1795588A1 (en) * | 2005-12-07 | 2007-06-13 | Cellerix, S.L. | Use of adipose tissue derived mesenchymal stem cells for the treatment of graft versus host disease |
| US8021882B2 (en) | 2006-08-24 | 2011-09-20 | Johnstone Brian H | Production of neural protective and regenerative factors from stem cells and treatment of nervous system conditions therewith |
| HUE036745T2 (hu) | 2006-11-03 | 2018-07-30 | Multiple Sclerosis Res Center Of New York | Csontvelõ eredetû mesenchimális õssejtek, mint a neurális progenitor sejtek forrásai |
| WO2011041240A1 (en) | 2009-09-30 | 2011-04-07 | The Brigham And Women's Hospital, Inc. | Tissue transplant compositions and methods for use |
| US8703180B1 (en) | 2007-10-23 | 2014-04-22 | Abbott Cardiovascular Systems Inc. | Multiple growth factor compositions, methods of fabrication, and methods of treatment |
| WO2009115581A2 (en) | 2008-03-19 | 2009-09-24 | Cryo-Save Ag | Improved cryopreservation of adipose tissue for the isolation of mesenchymal stem cells |
| US20090291061A1 (en) | 2008-05-21 | 2009-11-26 | Riordan Neil H | Stem cell therapy for blood vessel degeneration |
| DK2285951T3 (en) | 2008-05-28 | 2018-10-22 | Univ Ramot | TREATMENT OF CNS DISEASES OF CNS DISEASES |
| US20110129450A1 (en) | 2008-08-01 | 2011-06-02 | Orly Lazarov | Method of promoting neurogenesis by modulating secretase activities |
| WO2010028051A2 (en) | 2008-09-03 | 2010-03-11 | Florida State University Research Foundation, Inc. | Substituted heterocyclic mercaptosulfonamide metalloprotease inhibitors |
| CA2740578A1 (en) | 2008-10-17 | 2010-04-22 | Baxter International Inc. | Methods of obtaining cell populations from adipose tissue |
| JP5515319B2 (ja) | 2009-02-23 | 2014-06-11 | 富士レビオ株式会社 | 脂肪細胞への分化誘導培地及び方法 |
| TW201039815A (en) * | 2009-04-13 | 2010-11-16 | Resolvyx Pharmaceuticals Inc | Compositions and methods for the treatment of inflammation |
| EP2451943B1 (en) | 2009-07-09 | 2016-11-23 | TiGenix, S.A.U. | Methods and compositions for use in cellular therapies |
| MX349162B (es) * | 2010-01-04 | 2017-07-14 | Mapi Pharma Ltd * | Sistemas de deposito que comprende glatiramer o una sal farmacologicamente aceptable del mismo. |
| US8377885B2 (en) * | 2010-01-04 | 2013-02-19 | Mapi Pharma Ltd. | Depot systems comprising glatiramer or pharmacologically acceptable salt thereof |
| EP3345998B1 (en) | 2010-02-18 | 2024-08-14 | Osiris Therapeutics, Inc. | Immunocompatible chorionic membrane products |
| MX345730B (es) * | 2010-12-17 | 2017-02-14 | Anthrogenesis Corp | Células adherentes derivadas del amnios (amdac) para usarse en el tratamiento de enfermedades y trastornos relacionados con el sistema inmunitario. |
| EP2699317B1 (en) | 2011-04-21 | 2016-08-10 | Mapi Pharma Limited | Random pentapolymer for treatment of autoimmune diseases |
| US20130034524A1 (en) | 2011-08-03 | 2013-02-07 | Siamak Agha-Mohammadi | Non-Enzymatic Method for Harvesting Adipose-Derived Stromal Cells and Adipose-Derived Stem Cells from Fat and Lipo-Aspirate |
| SG2014013676A (en) | 2011-09-23 | 2014-05-29 | Cell Ideas Pty Ltd | Therapeutics using adipose cells and cell secretions |
| CL2011002642A1 (es) | 2011-10-24 | 2012-04-09 | Univ Del Desarrollo | Uso de una composicion formada por un glucocorticoide y una tiazolinediona que sirve para inducir la diferenciacion adipogenica en celulas madres. |
| EP2623110A1 (en) | 2012-01-31 | 2013-08-07 | CSL Behring GmbH | Factor XII inhibitors for the treatment of neurological inflammatory disorders |
| CN104350146A (zh) | 2012-03-12 | 2015-02-11 | 新加坡国立大学 | 从间充质细胞制备棕色脂肪组织(bat) |
| TWI642781B (zh) | 2014-02-06 | 2018-12-01 | 仲恩生醫科技股份有限公司 | 具優異細胞保護及免疫調節之ｑｕａｄｒｉ－正之基質細胞 |
| WO2015120388A1 (en) | 2014-02-10 | 2015-08-13 | Cytori Therapeutics, Inc. | Regenerative cell therapy for central nervous system (cns) disorders and ptsd |
| US20190046576A1 (en) | 2016-02-12 | 2019-02-14 | Cell Care Therapeutics | Adipose tissue derived mesenchymal stromal cell conditioned media and methods of making and using the same |
| US12161688B2 (en) | 2016-06-30 | 2024-12-10 | Mapi Pharma Ltd | Treatment of inflammatory bowel disease with long acting glatiramer and adipose-derived stem cells |
| WO2018211498A1 (en) | 2017-05-15 | 2018-11-22 | Stem Cell Medicine Ltd. | Treatment of multiple sclerosis with adipose-derived stem cells |
-
2017
- 2017-05-15 AU AU2017414803A patent/AU2017414803B2/en active Active
- 2017-05-15 WO PCT/IL2017/050535 patent/WO2018211486A1/en not_active Ceased
- 2017-05-15 US US16/613,355 patent/US11413311B2/en active Active
- 2017-05-15 JP JP2019563100A patent/JP7000458B2/ja not_active Expired - Fee Related
- 2017-05-15 CN CN201780091620.2A patent/CN110709091A/zh active Pending
- 2017-05-15 EP EP17909990.8A patent/EP3624815A4/en active Pending
- 2017-05-15 CA CA3062964A patent/CA3062964C/en active Active
-
2019
- 2019-10-31 IL IL270355A patent/IL270355B2/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL270355A (cg-RX-API-DMAC7.html) | 2019-12-31 |
| JP2020519658A (ja) | 2020-07-02 |
| CA3062964C (en) | 2024-11-12 |
| US11413311B2 (en) | 2022-08-16 |
| CA3062964A1 (en) | 2018-11-22 |
| CN110709091A (zh) | 2020-01-17 |
| WO2018211486A1 (en) | 2018-11-22 |
| AU2017414803B2 (en) | 2025-02-13 |
| EP3624815A1 (en) | 2020-03-25 |
| EP3624815A4 (en) | 2021-01-20 |
| US20200147141A1 (en) | 2020-05-14 |
| JP7000458B2 (ja) | 2022-02-10 |
| IL270355B2 (en) | 2023-06-01 |
| AU2017414803A1 (en) | 2019-12-05 |